📰 Analog Pharma News

Analog Pharma News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Analog Pharma. Real-time updates on events, politics, business and more.

Pheburane® (sodium phenylbutyrate) is now on the Medicaid Preferred Drug List in 10 states

January 23, 2024

/PRNewswire/ - Medunik USA, member of Duchesnay Pharmaceutical Group (DPG) one of the few anchor companies selected by the Government of Canada for its Global...

New Jersey United States Haute Normandie New Mexico New Hampshire North Dakota

Source: prnewswire.com

Pheburane® (sodium phenylbutyrate) coverage to reach ~80%

October 26, 2023

PRINCETON, N.J., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Medunik USA (member of Duchesnay Pharmaceutical Group, an international company selected in the...

New Jersey United States Tanya Carro States Pheburane Lucane Pharma Duchesnay Pharmaceutical Group

Source: globenewswire.com

Pheburane® (sodium phenylbutyrate) coverage rapidly expands to the benefit of Americans with certain urea cycle disorders (UCDs)

August 9, 2023

Pheburane® Now on the Preferred Drug List in 6 states and included on the Contract Drug List in California. PRINCETON, N.J., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Medunik USA (member of Duchesnay Pharmaceutical Group) is pleased to announce that an increasing number of Americans with certain urea cycle disorders (UCDs) now have access to Pheburane® (sodium phenylbutyrate) through a rapidly expanding network of key pharmacy benefit managers (PBMs), state Medicaid programs or Managed Medicai...

United States New Hampshire New Mexico New Jersey North Dakota Tanya Carro

Source: yahoo.com

Slynd® (drospirenone) is now covered by the Régie de

July 12, 2023

BLAINVILLE, Quebec, July 12, 2023 (GLOBE NEWSWIRE) -- Duchesnay Inc., a pharmaceutical company specializing in women’s health and member of Duchesnay...

United States Dany Hall Rachel Bruneau Maclinique Lebourgneuf Mariia Savchuk Information Department

Source: globenewswire.com

Ruzurgi® is Now Available and Covered by the Vast Majority of Public Health and Private Insurance Plans

July 11, 2023

Ruzurgi® (amifampridine) BLAINVILLE, Quebec, July 11, 2023 (GLOBE NEWSWIRE) — Médunik Canada, member of Duchesnay Pharmaceutical Group, is pleased to announce…

United States Jonathan Pratt Mariia Savchuk Health Canada Canadian Federal Court National Organization For Rare Disorders

Source: sina.com.hk

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

FDA approves ANDA of 20mg generic Nitisinone capsules

June 1, 2023

Nitisinone capsules are indicated for patients with hereditary tyrosinemia type 1 in combination with dietary restriction of tyrosine and phenylalanine - News - PharmaTimes

United States Marc Oliver Geinoz Biovitrum Orfadin Tanya Carro Drug Administration Swedish Orphan Biovitrum

Source: pharmatimes.com

Pheburane® Expanded Coverage with Commercial and Government

May 17, 2023

PRINCETON, NJ, May 17, 2023 (GLOBE NEWSWIRE) -- Medunik USA (member of Duchesnay Pharmaceutical Group) is pleased to announce that Pheburane® is now...

New Jersey United States Tanya Carro Beforetaking Pheburane Lucane Pharma Duchesnay Pharmaceutical Group

Source: globenewswire.com

ANALOG PHARMA AND DIPHARMA ANNOUNCE US FDA APPROVAL OF ABBREVIATED NEW DRUG APPLICATION (ANDA) OF GENERIC NITISINONE CAPSULES (TEMPERATURE STABLE)

June 21, 2022

Analog Pharma (“Analog”) and Dipharma S.A. (“Dipharma”) today announced that their nitisinone abbreviated new drug application (ANDA) has received final approval from the U.S. Food and Drug Administration. Nitisinone Capsules is a room temperature stable, AB-rated, generic equivalent of Swedish Orphan ...

Switzerland General Biovitrum Orfadin Dipharma Sa Drug Administration Analog Pharma Nitisinone Capsules

Source: pharmiweb.com